PMID: 8585768Oct 1, 1995Paper

Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge

Antiviral Research
H GhiasiS L Wechsler

Abstract

The herpes simplex virus type 1 (HSV-1) glycoprotein D (gD) gene was inserted into vectors pSVL or pRc/CMV under control of the SV40 late promoter or the human cytomegalovirus major immediate-early promoter, respectively. Intramuscular injection of mice with these gD-containing plasmids appeared to induce low levels of serum anti-gD antibody, as judged by the appearance of low levels of anti-HSV-1-neutralizing antibody and anti-gD ELISA responses in the serum of gD-DNA-vaccinated mice. As previously reported in other virus systems, vaccination with vector DNA also induced ELISA and neutralizing antibody titers. However, these titers were lower than those induced by the gD-containing plasmids. The ELISA and neutralization titers induced by the vectors appeared to be non-specific rather than directed at specific HSV-1 proteins, since serum from mice vaccinated with plasmid-gD immunoprecipitated significant amounts of gD from extracts of HSV-1-infected cells, while serum from mice vaccinated with vectors was unable to immunoprecipitate gD or any other obvious HSV-1 proteins. Neither pSVL-gD nor pRc/CMV-gD induced detectable lymphocyte proliferative or CTL responses. Vaccination with pSVL-gD provided a significant (P = 0.04, Fisher...Continue Reading

References

Sep 2, 1994·Science·N R RabinovichB F Hall
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·E F FynanH L Robinson

❮ Previous
Next ❯

Citations

Jun 1, 2011·Indian Journal of Virology : an Official Organ of Indian Virological Society·G NagarajanV V S Suryanarayana
Jan 1, 1997·Pharmacology & Therapeutics·D L MontgomeryM A Liu
Jun 6, 2000·Advanced Drug Delivery Reviews·A P Rolland, R J Mumper
Sep 29, 1999·Veterinary Microbiology·K M RuitenbergJ M Whalley
Dec 14, 1999·Microbes and Infection·H L Davis, M J McCluskie
Jan 13, 2004·Biomolecular Engineering·Florencia María Barbé-TuanaDavid Saitovitch
Jan 1, 1997·Annual Review of Immunology·J J DonnellyM A Liu
Jul 1, 1996·Emerging Infectious Diseases·R G Whalen
Jun 16, 2012·Future Virology·Xavier DervillezLbachir Benmohamed
May 2, 2012·Clinical & Developmental Immunology·Aziz Alami ChentoufiLbachir Benmohamed
Feb 3, 2016·Preparative Biochemistry & Biotechnology·Hongyan MaoZhenghai Ma
Sep 5, 2012·Progress in Retinal and Eye Research·A M RoweR L Hendricks
Nov 12, 2005·Current Eye Research·David M Koelle, Homayon Ghiasi
Jul 5, 2005·Expert Opinion on Investigational Drugs·U Kumaraguru, B T Rouse
May 4, 2012·Expert Review of Vaccines·Veronica L Fowler, Paul V Barnett
Sep 6, 2000·Clinical and Diagnostic Laboratory Immunology·J I SinD B Weiner
May 13, 2004·Clinical and Diagnostic Laboratory Immunology·L Aurelian
Jul 24, 2021·Expert Review of Vaccines·Vindya Nilakshi WijesingheSunil Kumar Lal
Nov 1, 1996·Journal of Virology·J C González ArmasD H Spector

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.